tirzepatide eye problems Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Vision loss: GLP-1 drugs like

PMID: 29386928 PMCID: PMC5683134 Krasnyi, Sadekova, Smolnova et al

Many women notice changes such as: Slower metabolism and increased fat storage, especially around the belly and hips Changes in insulin sensitivity and blood sugar regulation Shifts in hunger and fullness signals Hormone fluctuations in perimenopause can trigger fat-storage mechanisms, reduce lean muscle mass, and make traditional diet and exercise feel less effective

Do not rub or touch the injection site

Key Takeaways: Making an Informed Decision Combining phentermine and semaglutide lacks robust clinical evidence and carries real cardiovascular and gastrointestinal risks that warrant careful consideration